Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Pfizer launches portal for German healthcare professionals

Pfizermed.de will provide product information, training and patient materials

Pfizer Germany healthcare professionals portal

Pfizer Germany has launched an online portal that will offer healthcare professionals in the country services including training and downloadable patient materials.

The ärzteportal, or physician portal, also provides a full overview of Pfizer's product range and pipeline research, along with information on a number of different therapeutic areas.

The pharma company will use the Pfizermed.de portal, which requires doctors to log in using either DocCheck or a Pfizer user profile, to host product-related as well as 'product neutral' CME-accredited training.

The site contrasts with similar pharma websites run from the UK, among them Novartis' Gladstone and GlaxoSmithKline's health.gsk, which need separate, and clearly marked, sections for healthcare professionals and patients to remain compliant with the ABPI's Code of Practice.

2nd July 2012

From: Marketing

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

BL_Where_Now_20140721_CoverImage.jpg
3 Steps to Navigating Multichannel in Healthcare
You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign....
Online Physician Communities
How can pharma develop a more customer-centric approach?
Business pressures and customer needs will force pharma to focus on multichannel marketing in the next few years...
Exploring MINT: Part 2 - Indonesia
In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...